KHAN, M. A. (2026) “QBD-DRIVEN DESIGN AND PHARMACOKINETIC PROFILING OF REMOGLIFLOZIN ETABONATE SUSTAINED-RELEASE MATRIX TABLETS FOR DIABETES MANAGEMENT”, International Journal of Applied Pharmaceutics, 18(1), pp. 389–400. doi: 10.22159/ijap.2026v18i1.56445.